A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.
NCT04941898
·
clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Interventions
BIOLOGICAL:
PEGylated Recombinant Factor VIII
Sponsor
Takeda